Parsifal Capital Management LP Invests $21.17 Million in UnitedHealth Group Incorporated (NYSE:UNH)

Parsifal Capital Management LP purchased a new position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 36,200 shares of the healthcare conglomerate's stock, valued at approximately $21,165,000. UnitedHealth Group makes up approximately 1.4% of Parsifal Capital Management LP's portfolio, making the stock its 15th largest holding.

Several other large investors have also recently made changes to their positions in the stock. Kathleen S. Wright Associates Inc. acquired a new position in UnitedHealth Group during the 3rd quarter valued at about $27,000. Macroview Investment Management LLC increased its holdings in shares of UnitedHealth Group by 671.4% in the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate's stock valued at $28,000 after purchasing an additional 47 shares during the period. Bbjs Financial Advisors LLC acquired a new position in shares of UnitedHealth Group in the second quarter valued at about $31,000. Global Wealth Strategies & Associates increased its holdings in shares of UnitedHealth Group by 152.4% in the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate's stock valued at $31,000 after purchasing an additional 32 shares during the period. Finally, Signature Resources Capital Management LLC increased its holdings in shares of UnitedHealth Group by 40.0% in the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate's stock valued at $32,000 after purchasing an additional 18 shares during the period. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Up 0.9 %

NYSE:UNH traded up $5.56 during midday trading on Wednesday, reaching $610.79. The company had a trading volume of 3,957,103 shares, compared to its average volume of 3,849,386. The firm has a market capitalization of $562.10 billion, a price-to-earnings ratio of 39.43, a PEG ratio of 1.79 and a beta of 0.58. The stock's fifty day simple moving average is $586.72 and its 200-day simple moving average is $557.83. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $7.00 by $0.15. The firm had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. UnitedHealth Group's revenue was up 9.2% compared to the same quarter last year. During the same period last year, the business posted $6.56 earnings per share. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.38%. The ex-dividend date of this dividend is Monday, December 9th. UnitedHealth Group's dividend payout ratio (DPR) is 54.72%.

Wall Street Analyst Weigh In

UNH has been the topic of a number of research reports. HSBC lowered UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Thursday, October 17th. Stephens lowered their target price on UnitedHealth Group from $632.00 to $605.00 and set an "overweight" rating on the stock in a research note on Wednesday, October 16th. TD Cowen upped their target price on UnitedHealth Group from $601.00 to $609.00 and gave the stock a "buy" rating in a research note on Friday, October 18th. Royal Bank of Canada lowered their target price on UnitedHealth Group from $615.00 to $595.00 and set an "outperform" rating on the stock in a research note on Wednesday, October 16th. Finally, Morgan Stanley lowered their price target on UnitedHealth Group from $615.00 to $610.00 and set an "overweight" rating on the stock in a research report on Wednesday, October 16th. Four research analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, UnitedHealth Group currently has an average rating of "Moderate Buy" and an average target price of $621.58.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.